HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simvastatin Strongly Augments Proapoptotic, Anti-inflammatory and Cytotoxic Activity of Oxicam Derivatives in Doxorubicin-resistant Colon Cancer Cells.

AbstractBACKGROUND:
Incidence of cancer is still increasing. Chemotherapy is often unsuccessful; moreover, anticancer drugs cause serious side-effects. It is necessary to develop effective agents for combination therapies that would increase antitumor effects of treatment and reduce its side-effects.
MATERIALS AND METHODS:
Anticancer activity of oxicam derivatives (PR17 and PR18) alone and in combination with simvastatin on doxorubicin-resistant colon cancer cells was studied. Apoptosis was investigated via caspase-3 activation assay as well as via western blot analysis of expression of apoptotic components, B-cell lymphoma 2 protein (BCL2) and BCL2-associated X protein (BAX). Expression and activity of cyclo-oxygenase-2 (COX2) was also assessed.
RESULTS:
Oxicam derivatives induced apoptosis through a caspase-3-dependent pathway, up-regulated BAX expression, and down-regulated BCL2 expression. Additionally, oxicam derivatives reduced expression and activity of COX2. Effect of oxicam derivatives on these processes was strongly potentiated by simvastatin.
CONCLUSION:
Oxicam derivatives at low concentrations effectively inhibit growth of cancer cells after co-administration with simvastatin.
AuthorsKamila Środa-Pomianek, Krystyna Michalak, Anna Palko-Łabuz, Anna Uryga, Berenika Szczęśniak-Sięga, Olga Wesołowska
JournalAnticancer research (Anticancer Res) Vol. 39 Issue 2 Pg. 727-734 (Feb 2019) ISSN: 1791-7530 [Electronic] Greece
PMID30711951 (Publication Type: Journal Article)
CopyrightCopyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Chemical References
  • Antineoplastic Agents
  • BAX protein, human
  • BCL2 protein, human
  • Cyclic S-Oxides
  • Proto-Oncogene Proteins c-bcl-2
  • Thiazines
  • bcl-2-Associated X Protein
  • oxicam PR18
  • Doxorubicin
  • Simvastatin
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • CASP3 protein, human
  • Caspase 3
Topics
  • Antineoplastic Agents (pharmacology)
  • Apoptosis
  • Caspase 3 (metabolism)
  • Cell Line, Tumor
  • Cell Survival
  • Colonic Neoplasms (pathology)
  • Cyclic S-Oxides (chemistry, pharmacology)
  • Cyclooxygenase 2 (metabolism)
  • Doxorubicin (pharmacology)
  • Drug Resistance, Neoplasm
  • Drug Synergism
  • Enzyme Activation
  • Humans
  • Inhibitory Concentration 50
  • Proto-Oncogene Proteins c-bcl-2 (metabolism)
  • Simvastatin (pharmacology)
  • Thiazines (chemistry, pharmacology)
  • Up-Regulation
  • bcl-2-Associated X Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: